文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

重症急诊科患者的瘫痪中知晓:一项前瞻性队列研究

Awareness With Paralysis Among Critically Ill Emergency Department Patients: A Prospective Cohort Study.
PubMed 文献 · Crit Care Med · 2022-07-21
一句话结论机械通气急诊患者中瘫痪中知晓发生率为3.4%,与急诊使用罗库溴铵相关(OR 8.64),并导致感知威胁升高,增加PTSD风险。

该研究为多中心前瞻性前后对照临床试验的预先计划二次分析,纳入3个学术医学中心急诊科接受神经肌肉阻滞剂的机械通气成人患者388例。瘫痪中知晓(AWP)采用改良Brice问卷评估并由三位专家独立裁定,发生率为3.4%(13例),其中92.3%接受了罗库溴铵。接受罗库溴铵者AWP发生率为5.5%(12/230),未接受者为0.6%(1/158),OR 8.64(95%CI 1.11-67.15)。AWP患者感知威胁量表评分更高(15.6[5.8] vs 7.7[6.0],P<0.01),提示PTSD风险增加。作者认为需紧急开展研究以进一步量化并消除该脆弱人群的AWP。

要点

  • 机械通气急诊成人患者中AWP发生率为3.4%(13/388),多数(12/13,92.3%)接受了罗库溴铵。
  • 急诊使用罗库溴铵者AWP发生率5.5%(12/230),未使用者0.6%(1/158),OR 8.64(95%CI 1.11-67.15)。
  • AWP患者感知威胁量表评分高于无AWP者(15.6[5.8] vs 7.7[6.0],P<0.01),感知威胁处于PTSD因果通路。
  • 作者认为需紧急开展研究以进一步量化该脆弱人群的AWP并消除其发生。

适用人群与场景

  • 3个学术医学中心急诊科接受神经肌肉阻滞剂的机械通气成人患者(n=388)。

研究设计与关键结果

  • 研究类型:多中心、前瞻性、前后对照临床试验的预先计划二次分析,纳入3个学术医学中心急诊科388例接受神经肌肉阻滞剂的机械通气成人患者。
  • 主要终点:AWP采用改良Brice问卷评估并由三位专家独立裁定,发生率为3.4%(n=13),其中92.3%(12/13)接受了罗库溴铵。
  • 接受罗库溴铵者AWP发生率5.5%(12/230),未接受罗库溴铵者0.6%(1/158),OR 8.64(95%CI 1.11-67.15)。
  • 次要终点:AWP患者感知威胁量表平均评分高于无AWP者(15.6[5.8] vs 7.7[6.0],P<0.01)。

证据类型、等级与局限

  • 证据类型:多中心前瞻性前后对照临床试验的预先计划二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为AWP在机械通气急诊患者中占有令人担忧的比例,与急诊罗库溴铵暴露相关,并导致感知威胁升高,使患者处于更高PTSD风险。
  • 作者认为需紧急开展研究以进一步量化该脆弱人群的AWP并消除其发生。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: In mechanically ventilated patients, awareness with paralysis (AWP) can have devastating consequences, including post-traumatic stress disorder (PTSD), depression, and thoughts of suicide. Single-center data from the emergency department (ED) demonstrate an event rate for AWP factors higher than that reported from the operating room. However, there remains a lack of data on AWP among critically ill, mechanically ventilated patients. The objective was to assess the proportion of ED patients experiencing AWP and investigate modifiable variables associated with its occurrence.

DESIGN: An a priori planned secondary analysis of a multicenter, prospective, before-and-after clinical trial.

SETTING: The ED of three academic medical centers.

PATIENTS: Mechanically ventilated adult patients that received neuromuscular blockers.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: All data related to sedation and analgesia were collected. AWP was the primary outcome, assessed with the modified Brice questionnaire, and was independently adjudicated by three expert reviewers. Perceived threat, in the causal pathway for PTSD, was the secondary outcome. A total of 388 patients were studied. The proportion of patients experiencing AWP was 3.4% ( n = 13), the majority of whom received rocuronium ( n = 12/13; 92.3%). Among patients who received rocuronium, 5.5% ( n = 12/230) experienced AWP, compared with 0.6% ( n = 1/158) among patients who did not receive rocuronium in the ED (odds ratio, 8.64; 95% CI, 1.11-67.15). Patients experiencing AWP had a higher mean ( sd ) threat perception scale score, compared with patients without AWP (15.6 [5.8] vs 7.7 [6.0]; p < 0.01).

CONCLUSIONS: AWP was present in a concerning proportion of mechanically ventilated ED patients, was associated with rocuronium exposure in the ED, and led to increased levels of perceived threat, placing patients at greater risk for PTSD. Studies that aim to further quantify AWP in this vulnerable population and eliminate its occurrence are urgently needed.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Fuller BM, Pappal RD, Mohr NM, et al. Awareness With Paralysis Among Critically Ill Emergency Department Patients: A Prospective Cohort Study. Crit Care Med. 2022. PMID: 35866657. doi:10.1097/CCM.0000000000005626

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。